Alport syndrome is caused by mutations in the collagen type IV alpha 3-5 (COL4A3-5)
genes, resulting in glomerular basement membrane abnormalities and podocyte depletion.
1
Angiotensin II (AngII) promotes podocyte depletion through a complex cascade of profibrotic
cell signalling via inappropriate integrin-cell interaction with the glomerular basement
membrane, leading to abnormal cytoskeleton organization and apoptosis.
2
The progression of podocyte damage results in foot process effacement and proteinuria.
3
Transient receptor potential channel 6 and elevated AngII are associated with podocyte
injury in Alport syndrome and many other podocytopathies.
4
Nevertheless, podocyte research has been hampered by the lack of suitable models for
defining factors regulating podocyte survival and function. Primary cultures of human
podocytes only replicate for a short time, and cannot be maintained over long periods.
5
Additionally, most in vitro research has been conducted using immortalized podocytes
(IMM-PODs), which are limited to a single genetic background and limited differentiation
capacity.
6
Induced pluripotent stem cells (iPSCs) using adult cell reprogramming
7
provide an unprecedented opportunity to elucidate disease mechanisms in vitro and
provide tools for understanding genetic disease by decoding genotype-to-phenotype
correlation.
8
Kidney podocytes generated through the directed differentiation of iPSCs (iPSC-PODs),
maintain podocyte characteristics comparable to IMM-PODs or primary podocytes.
9
,
S10,S11 Therefore, the differentiation of iPSCs from Alport syndrome patientsS12 provides
a long-term and self-renewing strategy to study X-linked Alport syndrome.
The precise molecular mechanism underlying X-linked COL4A5 mutations promoting Alport
syndrome remains unclear. Podocyte depletion through apoptosis in Alport syndrome
may result from an overexpression of tumour necrosis factor alpha (TNF-α),
2
produced by infiltrating macrophages, or possibly from elevated reabsorption of protein
in proximal tubular epithelial cells.
3
In Alport syndrome, the accumulation of misfolded proteins in podocyte rough endoplasmic
reticulum (RER) may induce the unfolded-protein response for missense mutations.S13
Pathological endpoints of RER stress include podocyte apoptosis and autophagy due
to defective localization of COL4A5.S14 There is growing interest in the therapeutic
use of chaperones for treating inherited renal disease. The protein-folding chaperone,
4-phenylbutyric acid (PBA) can reduce RER size by resolving the aggregation of the
misfolded cytoplasmic collagen matrix.S15,16 The elucidation of how gene COL4A5 mutations
cause podocyte injury is a fundamental step for future studies to improve disease
outcomes.
This study compares iPSCs derived from a male patient with X-linked Alport syndrome
due to a COL4A5 missense mutation (p.G624D) to wild-type (WT) control subjects presenting
with normal renal function. Pluripotency was confirmed in WT and Alport G624D iPSCs
before the directed differentiation into podocytes.
9
Cell ultrastructure of iPSC-PODs was assessed using transmission electron microscopy
and chaperone treatment using PBA was found to have a protective effect on Alport
iPSC-PODs by reducing the size of dysregulated RER due to protein accumulation. Increased
endoplasmic reticulum stress genes encoding for Binding immunoglobulin protein (BiP),
CCAAT/enhancer-binding protein homologous protein (CHOP) and X-box binding protein
1 (XBP1) were upregulated in Alport iPSC-PODs D10 comparing to WT iPSC-PODs. Furthermore,
Alport iPSC-PODs were more susceptible to TNF-α–mediated apoptosis, and an elevated
intracellular calcium influx (caused by AngII) when compared to WT controls. Taken
together, we provide evidence that Alport iPSCs maintain genotype-phenotype correlations
to explore patient-relevant cellular mechanisms targeted for therapeutic development.
Methods
See Supplementary Methods.
Results
Dermal skin fibroblasts outgrowths were cultured from an Alport patient with the hemizygous
X-linked COL4A5 missense mutation, p.G624D in exon 46 (G624D),S16 which is common
in Europe, accounting for approximately 40% of the cases in Poland. Primary fibroblast
outgrowths were desmin-positive with COL4A5 protein expression localized in a perinuclear
pattern (Supplementary Figure S1). The fibroblasts were transduced into iPSCs using
nonintegrating Sendai virus reprogramming. The iPSC colonies were alkaline phosphatase-positive
and expressed the pluripotency markers: OCT4, SSEA4, TRA-1-60, and TRA-1-81. Moreover,
Alport syndrome iPSC colonies retained COL4A5 expression, analogous to primary fibroblasts
(Supplementary Figure S1). Undifferentiated Alport G624D iPSCs that were karyotypically
normal were engrafted under the kidney capsule of nonobese diabetic–severe combined
immunodeficiency mice confirming teratoma formation after 12 weeks (Supplementary
Figure S1). Both WT and G624D iPSCs were differentiated into iPSC-PODs as previously
reportedS12 that expressed PODXL, a mature podocyte marker (Figure 1). There was a
significant difference in F-actin organization, measured as mean cell size as defined
by F-actin between control WT and G624D Alport iPSC-PODs following TNF-α stimulation
(Figure 1).
Figure 1
Differentiation of G624D induced pluripotent stem cells (iPSCs) into iPSC podocytes
(PODs) and F-actin cytoskeletal arrangement in response to tumor necrosis factor alpha
(TNF-α). (a-c) Wild-type (WT) iPSC-PODs expressed podocyte specific markers such as
PODXL in the cytoplasm, also observable in (d-f) G624D iPSC-PODs. Confocal images
of F-actin labelled (g, h) WT and (i, j) G624D iPSC-PODs before and after TNF-α induced
cell death. Differences were found in the F-actin cytoskeletal arrangement between
WT and G624D D10 iPSC-PODs, seeded at the same cell density. Two-hour treatment of
TNF-α caused cell death and podocyte detachment (arrows) in both WT and G624D iPSC-POD
D10 (original magnifications ×20). (k) Quantification of the mean cell area showed
that G624D iPSC-POD D10 exhibited a significantly smaller mean cell area than WT.
TNF-α caused a significant reduction in mean cell area in WT, but had less influence
on the cytoskeleton rearrangement in G624D. N = 3 to 5; 5 fields; All data were presented
as mean + SEM.
Discussion
Previously, we reported that the chaperone PBA alleviated accumulated misfolded protein
in the endoplasmic reticulum of Alport fibroblasts, expressing COL4A3, 4, and 5.S16
Therefore, PBA was added to G624D Alport iPSC-PODs to determine the effectiveness
to attenuate misfolded RER COL4A5 protein. By transmission electron microscopy, the
RER of G624D Alport iPSC-PODs appeared dilated and enlarged (Yellow M; Figure 2) compared
to WT and IMM-PODs (Red dots; Figure 2). The addition of PBA reduced both the perinuclear
and average RER area of the Alport iPSC-PODs compared to WT and IMM-POD controls.
Using quantitative polymerase chain reaction, there was an upregulation of endoplasmic
reticulum stress markers: CHOP, BiP and unspliced XBP1 (usXBP1) and spliced XBP1 (sXBP1)
in G624D Alport iPSC-PODs after 10 days of differentiation, compared to WT iPSC-PODs
(Figure 2).
Figure 2
Dysregulated rough endoplasmic reticulum (RER) was found exclusively in G624D induced
pluripotent stem cell (iPSCs)–podocyte (POD) D10 and the treatment of 4-phenylbutyric
acid (PBA) reduced the RER enlargement. Representative images of transmission electron
microscopy analysis are shown as (a) immortalized (IMM)–PODs T37, (b) wild-type (WT),
and (c) G624D iPSC-PODs D10. IMM-PODs T37 and WT iPSC-PODs D10 (Red dot showing luminal
widths) did not show any abnormality in the RER. Enlarged RER organelle (Yellow M)
was found in G624D iPSC-PODs D10. (d) Quantification of perinuclear RER percentage
area revealed differences in mean area of cell lines (n = 20). However, PBA treatment
was shown to reduce the total perinuclear RER percentage area of G624D iPSC-PODs (P =
0.0021), not statistically significant in IMM-POD and WT controls (original magnification, ×40,000;
scale bars: 0.5 μm). (e) Average RER volume was also taken as a factor of the number
of RER units in a perinuclear location. Supplementary treatment with PBA again reduced
the average RER volume to significant differences in the G624D (P = 0.0332). Two-way
analysis of variance with Tukey’s post hoc test. All data were presented as mean ±
SEM. The gene expression of endoplasmic reticulum stress markers (f) CHOP, (g) BiP,
(h) usXBP1, and (i) sXBP1 were quantified using quantitative polymerase chain reaction.
Following 10 days after differentiation, G624D iPSC-PODs showed an upregulated mRNA
expression of endoplasmic reticulum stress markers, CHOP, BiP, uSXBP1, and sSXBP1
compared to WT iPSC-POD controls.
Alport iPSC-POD susceptibility to TNF-α–mediated apoptosis was also investigated.
WT, G624D iPSC-PODs, and IMM-PODs were exposed to TNF-α for 2 hours to stimulate podocyte
injury (Figure 3). Importantly, only G624D iPSC-PODs displayed a significant increase
in caspase-positive cells correlating with cell death over 2 hours (38.8 ± 6.9 cells
vs. 69.8 ± 6.9 cells; P=0.0332), compared to baseline (Figure 3). This indicated an
increased susceptibility of G624D Alport iPSC-PODs to TNF-α–stimulated apoptosis compared
to WT and IMM-PODs without the COL4A5 mutation.
Figure 3
G624D displayed increased susceptibility to tumor necrosis factor alpha (TNF-α)–stimulated
podocyte death after 2-hour TNF-α exposure. Representative images of the vehicle and
after a 2-hour treatment with media containing 20 ng/ml TNF-α are shown for (a and
d) immortalized (IMM)–podocytes (PODs), (b and e) wild-type (WT), and (c and f) G624D
induced pluripotent stem cells (iPSC)–PODs. (g) All cell lines (n = 4) were analyzed
for the presence of caspase-positive cells using the caspase inhibitor VAD-FMK conjugated
to sulfo-rhodamine (Red-VAD-FMK) as the fluorescent in situ marker. Comparisons within
cell lines outlined increased caspase positive cells in the G624D iPSC-PODs after
the 2-hour TNF-α exposure (P < 0.05) compared to t = 0. The other two cells displayed
trends of increased caspase positive cells after 2 hours regardless of vehicle or
TNF-α treatment without significant differences. All data were compared by one-way
analysis of variance with Tukey’s post hoc test form comparisons made only within
cell lines with/without TNF-α treatment. All data were presented as mean ± SEM. Differential
interference contrast microscopy was performed to assess the susceptibility of the
diseased iPSC-PODs to retraction and cell death following the addition of TNF-α over
16 hours of culture. In (h-j) WT iPSC-PODs, cell blebbing, and retraction, which represent
morphological hallmarks of apoptosis, were observed at ~600 minutes, compared to (k-m)
G624D iPSC-POD D10, at ~360 minutes. The time-lapse imaging provided evidence that
G624D iPSC-PODs D10 displayed apoptotic morphology and were more susceptible to early-onset
cell death compared to WT cells.
Differential interference contrast microscopy was used to visualize D10 G624D Alport
and WT iPSC-PODs to examine the susceptibility to cell death over an extended period
of TNF-α exposure for 16 hours (Figure 3). The assessment of time-lapsed, live-cell
imaging in Alport iPSC-PODs, compared to WT iPSC-PODs (Figure 3), shows the retraction
of podocytes and evidence that podocytes displayed apoptotic morphology (including
membrane blebbing) earlier in disease cells compared to WT cells (Supplementary Movies
S1 and S2).
In a previous study, we showed that AngII promotes concentration-dependent elevations
of intracellular calcium that were particularly sensitive to the AngII type-1 receptor
antagonist, losartan.S12 In this study, we performed an AngII responsiveness assay
on WT and G624D Alport iPSC-PODs D10 following 24-hour stimulation of TNF-α (Supplementary
Figure S2). The increase in 340/380 emission ratio indicated the binding of more cytosolic
free Ca2+ to FURA-2 AM, a Ca2+ fluorescent indicator. As a result, the excitation
wavelength changed from 380 nm to 340 nm; the increase in 340/380 emission ratio indicated
an increase intracellular influx of Ca2+ ions. The addition of AngII is an agonist
to intracellular calcium influx. We report that prior exposure of Alport iPSC-PODs
to TNF-α for 24 hours had a marked impact on the AngII agonistic effects leading to
increased intracellular calcium influx, adversely compared to the WT iPSC-PODs at
D10.
Conclusions
These studies have shown that iPSCs are a valuable in vitro model system to study
the function of genetic variation. Using iPSC-PODs, we identified TNF-α as a trigger
that induces susceptibility of Alport iPSC-derived podocytes to depletion. The chemical
chaperone, PBA was found to eliminate morphological aberrations of the RER due to
collagen accumulation in Alport G624D iPSC-derived podocytes. iPSC-POD disease modelling
and toxicology screening can ultimately enable clinicians to optimize personalized
medicine opening up new avenues for affected individuals.
Disclosure
The authors declare no competing interests.